CASP3 and neoplasm: Notably, GSDME was recently shown to be cleaved and activated by caspase-3 with a role in anti-tumor immunity (141, 142) (Table 1), driving chemotherapy drug-induced normal-tissue damage or viral infection-mediated secondary necrosis (74, 75) as confirmed by STRING analysis (86) (Figure 4E, Table 1).